@article{3192240,
    title = "Patient-reported outcomes (PROs) from JAVELIN Bladder 100: Avelumab
first-line (1L) maintenance plus best supportive care (BSC) vs BSC alone
for advanced urothelial carcinoma (UC)",
    author = "Powles, T. B. and Kopyltsov, E. and Su, P-J. and Parnis, F. X. and Park, and S. H. and Yamamoto, Y. and Fong, P. C. and Tournigand, C. and Duran, M. and A. Climent and Bamias, A. and Caserta, C. and Chang, J. and Yan, E. and and di Pietro, A. and Wang, J. and Grivas, P.",
    journal = "Annals of Oncology",
    year = "2020",
    volume = "31",
    number = "4",
    pages = "S578-S579",
    publisher = "Elsevier",
    issn = "0923-7534, 1569-8041",
    doi = "10.1016/j.annonc.2020.08.817"
}